Increasing prevalence of cardiovascular diseases in North America is expected to bolster the market growth
North America holds dominant position in the global swab market, owing to high prevalence of cardiovascular disease, which leads to angioplasty and other surgeries. According to the American Heart Association, 2016, cardiovascular diseases accounted for around 17.3 million deaths annually worldwide, whereas an estimated 23.3 million people are expected to die from cardiovascular disease by 2030.
Moreover, increasing geriatric population susceptible to cardiovascular disease in this region is expected to bolster the market growth over the forecast period. According to the American Heart Association, December 2015, an estimated 85.6 million Americans suffers from some form of cardiovascular disease and nearly 50% of African and America adults are diagnosed with cardiovascular disease in which women comprised around 48% and men around 46%
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients